Role of mitochondria in Parkinson disease

Biological Chemistry

Volumn 380, Issue 7-8, 1999, Pages 865-870

  Kösel, Siegfried ^a   Hofhaus, Götz ^b   Maassen, Alexander ^b   Vieregge, Peter ^c   Graeber, Manuel B ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

Apoptosis; Complex I; Mitochondrial DNA; Neurodegeneration

Indexed keywords

ALPHA SYNUCLEIN; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

APOPTOSIS; CHROMOSOME 4; CHROMOSOME 6; DNA SEQUENCE; GENE MUTATION; HUMAN; LEWY BODY; MISSENSE MUTATION; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS;

APOPTOSIS; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; PARKINSON DISEASE; POINT MUTATION; SUBSTANTIA NIGRA;

PARKINSONIA;

EID: 0344631658     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.106     Document Type: Review

References (48)

1. Anderson, S., Bankier, A.T., Barrell, B.G., de Bruijn, M.H.L., Coulson, A.R., Drouin, J., Eperon, I.C., Nierlich, D.P., Roe, B.A., Sanger, F., Schreier, P.H., Smith, A.J.H., Staden, R., and Young, I.G. (1981). Sequence organisation of the human mitochondrial genome. Nature 290, 457-465.
2. Anglade, P., Vyas, S., Javoy Agid, F., Herrero, M.T., Michel, P.P., Marquez, J., Mouatt Prigent, A., Ruberg, M., Hirsch, E.C., and Agid, Y. (1997). Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12, 25-31.
3. Banati, R.B., Daniel, S.E., and Blunt, S.B. (1998). Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov. Disord. 13, 221-227.
4. Benecke, R., Strümper, P., and Weiss, H. (1993). Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain 116, 1451-1463.
5. Bindoff, L.A., Birch Machin, M.A., Cartlidge, N.E., Parker, W.D., Jr., and Turnbull, D.M. (1991). Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J. Neurol. Sci. 104, 203-208.
6. Brown, M.D., Shoffner, J.M., Kim, Y.L., Jum, A.S., Graham, B.H., Cabell, M.F., Gurley, D.S., and Wallace, D.C. (1996). Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. Am. J. Med. Genet. 61, 283-289.
7. Dragunow, M., Faull, R.L.M., Lawlor, P., Beilharz, E.J., Singleton, K., Walker, E.B., and Mee, E. (1995). In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 6, 1053-1057.
8. Duncan, A.M.V., Chow, W., Robinson, B.H. (1992). Localization of the human 75-kDal Fe-S protein of NADH-coenzyme Q reductase gene (NDUPS1) to 2q33→q34. Cytogenet. Cell. Genet. 60, 212-213.
9. Egensperger, R., Kösel, S., Schnopp, N.M., Mehraein, P., and Graeber, M.B. (1997). Association of the mitochondrial tRNA-(A4336G) mutation with Alzheimer's and Parkinson's diseases. Neuropathol. Appl. Neurobiol. 23, 315-321.
10. Graeber, M.B., Grasbon-Frodl, E., Abell-Aleff, P., and Kösel, S. (1999). Nigral neurons are likely to die of a mechanism other than classical apoptosis in Parkinson's disease. In: Parkinsonism and Related Disorders, in press.
11. Grasbon-Frodl, E.M., Kösel, S., Sprinzl, M., von Eitzen, U., Mehraein, P., and Graeber, M.B. (1999). Two novel point mutations of mitochondrial tRNA genes in histologically confirmed Parkinson disease. Neurogenetics 2, 121-127.
12. Gu, M., Cooper, J.M., Taanman, J.W., and Schapira, A.H.V. (1998). Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann. Neurol. 44, 177-186.
13. Hartley, A., Cooper, J.M., and Schapira, A.H.V. (1993). Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease. Brain Res. 627, 349-353.
14. Hattori, N., Yoshino, H., Tanaka, M., Suzuki, H., and Mizuno, Y. (1998). Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease. Genomics 49, 52-58.
15. Hirsch, T., Marchetti, P., Susin, S.A., Dallaporta, B., Zamzami, N., Marzo, I., Geuskens, M., and Kroemer, G. (1997). The apoptosis-necrosis paradox. Apoptogenetic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15, 1573-1581.
16. Ikebe, S., Tanaka, M., and Ozawa, T. (1995). Point mutations of mitochondrial genome in Parkinson's disease. Mol. Brain Res. 28, 281-295.
17. Janetzky, B., Hauck, S., Youdim, M.B.H., Riederer, P., Jellinger, K., Pantucek, F., Zöchling, R., Boissl, K.W., and Reichmann, H. (1994). Unaltered aconitase activity, but decreased complex I activity in Substantia nigra pars compacta of patients with Parkinson's disease. Neurosci. Lett. 169, 126-128.
18. Kim, J.W., Lee, Y., Kang, H.B., Chose, Y.K., Chung, T.W., Chang, S.Y., Lee, K.S., Choe, I.S. (1997). Cloning of the human cDNA sequence encoding the NADH:ubiquinone oxidoreductase MLRQ subunit. Biochem. Mol. Biol. Int.43, 669-675.
19. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., and Shimizu, N. (1998). Mutations in the parkin gene cause autosomal recessive juvenileparkinsonism. Nature 392, 605-608.
20. Kösel, S., Egensperger, R., Schnopp, N.M., and Graeber, M.B. (1997a). The common deletion in not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction. Movement Disorders 12, 639-645.
21. Kösel, S., Egensperger, R., von Eitzen, U., Mehraein, P., and Graeber, M.B. (1997b). On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathol. 93, 105-108.
22. Kösel, S., Grasbon-Frodl, E.M., Mautsch, U., Egensperger, R., von Eitzen, U., Frishman, D., Hofmann, S., Gerbitz, K.-D., Mehraein, P., and Graeber, M.B. (1998). Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease. Neurogenetics 1, 197-204.
23. Krige, D., Carroll, M.T., Cooper, J.M., Marsden, C.D., and Schapira, A.H. (1992). Platelet mitochondrial function in Parkinson's disease. Ann. Neurol. 32, 782-788.
24. Krüger, R., Kühn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J.T., Schols, L., and Riess, O. (1998). Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nature Genet. 18, 106-108.
25. Langston, J.W., Ballard, P., Tetrud, J.W., and Irwin, I. (1983). Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Anal. Biochem. 219, 979-980.
26. Lemasters, J.J., Nieminen, A.L., Quian, T., Trost, L.C., Elmore, S.P., Nishimura, Y., Crowe, R.A., Cascio, W.E., Bradham, C.A., Brenner, D.A., and Herman, B. (1998). The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366, 177-196.
27. Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M.J., Jonnalagada, S., Chernova, T., Dehejia, A., Lavedan, C., Gasser, T., Steinbach, P.J., Wilkinson, K.D., and Polymeropoulos, M.H. (1998). The ubiquitin pathway in Parkinson's disease. Nature 395, 451-452.
28. Lestienne, P., Nelson, J., Riederer, P., Jellinger, K., and Reichmann, H. (1990). Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect. J. Neurochem. 55, 1810-1812.
29. Lucking, C.B., Abbas, N., Durr, A., Bonifati, V., Bonnet, A.M., de Broucker, T., De Michele, G., Wood, N.W., Agid, Y., and Brice, A. (1998). Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on genetic susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Group. Lancet 352, 1355-1356.
30. Mann, V.M., Cooper, J.M., and Schapira, A.H.V. (1992). Quantitation of mitochondrial DNA deletion in Parkinson's disease. FEBS Lett. 299, 218-222.
31. McNaught, K.S., Thull, U., Carrupt, P.A., Altomare, C., Cellamare, S., Carotti, A., Testa, B., Jenner, P., and Marsden, C.D. (1996). Effects of isoquinoline derivates structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration. Biochem. Pharmacol. 51, 1503-1511.
32. Mizuno, Y., Ohta, S. Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T., and Kagawa, Y. (1989). Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163, 1450-1455.
33. Mochizuki, H., Goto, K., Mori, H., and Mizuno, Y. (1996). Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137, 120-123.
34. Ozawa, T., Tanaka, M., Ikebe, S., Ohno, K., Kondo, T., and Mizuno, Y. (1990). Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by kinetic PCR analysis. Biochem. Biophys. Res. Commun. 172, 483-489.
35. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W.G., Lazzarini, A.M., Duvoisin, R.C., Diiorio, G., Golbe, L.I., and Nussbaum, R.L. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
36. Russell, M.W., du Manoir, S., Collins, F.S., Brody, L.C. (1997). Cloning of the human NADH: ubiquinone oxidoreductase subunit B13: localization to chromosome 7q32 and identification of a pseudogene on 11p15. Mamm. Genome 8, 60-61.
37. Schapira, A.H.V., Cooper, J.M., Dexter, D., Jenner, P., Clark, J.B., and Marsden, C.D. (1989). Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1, 1269.
38. Schapira, A.H.V., Mann, V.M., Cooper, J.M., Dexter, D., Daniel, S.E., Jenner, P., Clark, J.B., and Marsden, C.D. (1990). Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55, 2142-2145.
39. Shoffner, J.M., Brown, M.D., Torrini, A., Lott, M.T., Cabell, M.F., Mirra, S.S., Beal, M.F., Yang, C.-C., Gearing, M., Salvo, R., Watts, R.L., Juncos, J.L., Hansen, L.A., Crain, B.J., Fayed, M., Reckord, C.L., and Wallace, D.C. (1993). Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17, 171-184.
40. Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy Agid, F., Jenner, P., and Marsden, C.D. (1994). Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348-355.
41. Susin, S.A., Zamzami, N., and Kroemer, G. (1998). Mitochondria as regulators of apoptosis: doubt no more. Biochim. Biophys. Acta 1366, 151-165.
42. Swerdlow, R.H., Parks, J.K., Miller, S.W., Tuttle, J.B., Trimmer, P.A., Sheehan, J.P., Bennett, J.P., Davis, R.E., and Parker, W.D. (1996). Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40, 663-671.
43. Swerdlow, R.H., Parks, J.K., Davis, J.N., Cassarino, D.S., Trimmer, P.A., Currie, L.J., Dougherty, J., Bridges, W.S., Bennett, J.P., Wooten, G.F., and Parker, W.D. (1998). Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Ann. Neurol. 44, 873-881.
44. Tabrizi, S.J., Cooper, J.M., and Schapira, A.H.V. (1998). Mitochondrial-DNA in focal dystonia - a cybrid analysis. Ann. Neurol. 44, 258-261.
45. Tompkins, M.M., Basgall, E.J., Zamrini, E., and Hill, W.D. (1997). Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigra neurons. Am. J. Pathol. 150, 119-131.
46. Vieregge, P., Hagenah, J., Heberlein, I., Klein, C., and Ludin, H.-P. (1999). Parkinson disease in twins: A follow-up study. Neurology, in press.
47. Wallace, D.C. (1992). Diseases of the mitochondrial DNA. Annu. Rev. Biochem. 61, 1175-1212.
48. Wooten, G.F., Currie, L.J., Bennett, J.P., Harrison, M.B., Trugman, J.M., and Parker, W.D. (1997). Maternal inheritance in Parkinson's disease. Ann. Neurol. 41, 265-268.